Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Gobom

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
Acta Neuropathologica|March 17, 2025
Biofluid-based staging of Alzheimer's diseaseJuan Lantero-Rodriguez, Laia Montoliu-Gaya, Nicholas J Ashton, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosisDaisuke Yasui, Daniel Weatherill, Laura Dugom, et al.
Research Square|August 7, 2024
Synaptic protein CSF levels relate to memory scores in individuals without dementiaKirsten E J Wesenhagen, Diederick M de Leeuw, Jori Tomassen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 16, 2022
Effects of age, amyloid, sex, and <i>APOE</i> ε4 on the CSF proteome in normal cognitionKirsten E J Wesenhagen, Johan Gobom, Isabelle Bos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 12, 2025
Plasma tau biomarkers are distinctly associated with tau tangles and decreased with Lewy body pathologyLaia Montoliu-Gaya, Elizabeth Valeriano-Lorenzo, Nicholas J Ashton, et al.
Clinical Biochemistry|January 15, 2013
Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serumBryan Krastins, Amol Prakash, David A Sarracino, et al.
Alzheimer'S Research & Therapy|March 3, 2025
Synaptic protein CSF levels relate to memory scores in individuals without dementiaKirsten E J Wesenhagen, Diederick M de Leeuw, Jori Tomassen, et al.
Acta Neuropathologica|September 30, 2025
Reversible tau hyperphosphorylation in hibernation: a blood biomarker and brain tissue studyWagner S Brum, Laia Montoliu-Gaya, Gunnar Brinkmalm, et al.
Brain : a Journal of Neurology|January 13, 2021
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomicsBetty M Tijms, Johan Gobom, Lianne Reus, et al.
Brain Communications|July 11, 2025
Cerebrospinal fluid proteomic profiling of cognitively unimpaired individuals with suspected non-Alzheimer's disease pathophysiologyAurore Delvenne, Johan Gobom, Lianne M Reus, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Acta Neuropathologica|March 17, 2025
Biofluid-based staging of Alzheimer's diseaseJuan Lantero-Rodriguez, Laia Montoliu-Gaya, Nicholas J Ashton, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosisDaisuke Yasui, Daniel Weatherill, Laura Dugom, et al.
Research Square|August 7, 2024
Synaptic protein CSF levels relate to memory scores in individuals without dementiaKirsten E J Wesenhagen, Diederick M de Leeuw, Jori Tomassen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 16, 2022
Effects of age, amyloid, sex, and <i>APOE</i> ε4 on the CSF proteome in normal cognitionKirsten E J Wesenhagen, Johan Gobom, Isabelle Bos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 12, 2025
Plasma tau biomarkers are distinctly associated with tau tangles and decreased with Lewy body pathologyLaia Montoliu-Gaya, Elizabeth Valeriano-Lorenzo, Nicholas J Ashton, et al.
Clinical Biochemistry|January 15, 2013
Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serumBryan Krastins, Amol Prakash, David A Sarracino, et al.
Alzheimer'S Research & Therapy|March 3, 2025
Synaptic protein CSF levels relate to memory scores in individuals without dementiaKirsten E J Wesenhagen, Diederick M de Leeuw, Jori Tomassen, et al.
Acta Neuropathologica|September 30, 2025
Reversible tau hyperphosphorylation in hibernation: a blood biomarker and brain tissue studyWagner S Brum, Laia Montoliu-Gaya, Gunnar Brinkmalm, et al.
Brain : a Journal of Neurology|January 13, 2021
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomicsBetty M Tijms, Johan Gobom, Lianne Reus, et al.
Brain Communications|July 11, 2025
Cerebrospinal fluid proteomic profiling of cognitively unimpaired individuals with suspected non-Alzheimer's disease pathophysiologyAurore Delvenne, Johan Gobom, Lianne M Reus, et al.
Pageof 14